Information Item

Erratum

In the article “Summary Report From the 13th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting” by RamaswamyGovindan in the January 2014 issue (2014;15:16-20; doi:10.1016/j.cllc.2013.11.010) the disclosure was incorrectly reported. The correctDisclosure is as follows, Dr. Ramaswamy Govindan received honoraria from Bristol Meyers Squibb, Covidien, Merck, Pfizer, Glaxo SmithKline and has served as consultant for Novartis as well.

1525-7304/$ - see frontmatter ª 2014 Elsevier Inc. All rights reserved.http://dx.doi.org/10.1016/j.cllc.2014.01.002 Clinical Lung Cancer March 2014 - 171